Called Contour pro, the new system uses a secure Bluetooth connection to transmit, from the point of care to a PDA, the test data and patient’s key data for further processing within the hospital’s IT system. ‘This solution enables the hospital staff to access all patient and quality control results and provides an accessible real-time patient record at bedside,’ Bayer reports. ‘Contour Pro possesses the well established “no coding” technology that delivers accurate results and therefore improves therapeutic success. Coding errors are a major problem because they can lead to inaccuracies in blood glucose measurements and, in the long term, inaccurate readings can hide poor glycaemic control, which can lead to serious complications.’
The device manages not only glucose, but all POC bedside testing data, and has no maltose or galactose interferences, Bayer points out. ‘An automatic interference correction electrode provides superior stability with common reducing substances.’
In Europe, the Contour Pro blood glucose monitoring system will be launched in selected areas early in 2008.
Full details: www.viva.vita.bayerhealthcare.com